The National Retail Federation event in 2024 was all about artificial intelligence. The same can be said for NRF 2025. Click ...
Zacks Investment Research on MSN7h
Ultragenyx Q4 Loss Wider Than Expected, Revenues Increase Y/YUltragenyx Pharmaceutical RARE reported fourth-quarter 2024 loss of $1.39 per share, wider than the Zacks Consensus Estimate ...
A group of former leaders from health comms giant Inizio Evoke have come together to launch Flex Marketing, a new agency ...
It’s critical to understand what a digitally savvy HCP is in 2025 and what’s impeding pharma's communications with this ...
The Lodi Winegrape Commission Board of Directors proudly recognizes Executive Director Stuart Spencer for his 25 years of ...
In this process, royalty recipients often face the issue where multiple small future royalty streams cannot fulfill ongoing large lump-sum R&D funding needs. The mismatch is where Royalty Pharma ...
Discover key insights from West Pharmaceutical Services' Q4 2024 earnings call, highlighting growth in GLP-1 elastomers, biologics, and HVP components.
As Alnylam Pharmaceuticals approaches its highly anticipated March 23 FDA decision date for a potential expansion of Amvuttra ...
Pharma, telecom shine, while IT and oil & gas face pressure. Rural recovery aids FMCG, but urban consumption lags. Banking steady despite NIM squeeze. What's next?
In honor of Rare Disease Day on February 28, 2025, we will publish a series of posts throughout the month on As Prescribed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback